Documents DATA MONITORING COMMITTEES: A Regulator’s Perspective Mary A. Foulkes, Ph.D. Office of...

Slide 1 DATA MONITORING COMMITTEES: A Regulator’s Perspective Mary A. Foulkes, Ph.D. Office of Biostatistics and Epidemiology Center for Biologics Evaluation and Research…

Documents 1 FDA DRAFT GUIDANCE ON CLINICAL TRIAL DATA MONTORING COMMITTEES Susan S. Ellenberg, Ph.D. Office of...

Slide 1 1 FDA DRAFT GUIDANCE ON CLINICAL TRIAL DATA MONTORING COMMITTEES Susan S. Ellenberg, Ph.D. Office of Biostatistics and Epidemiology Center for Biologics Evaluation…